Clinical Trial Update: A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update evaluating Lantus (insulin glargine) dosing algorithms to achieve normal blood glucose targets in adults with uncontroll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED